Team |
Andrew Kelso, PhD
Andrew Kelso, PhD

Andrew Kelso, PhD

Scientist II

Technology Development

Drew is responsible for analyzing Life Edit's novel genome editing enzymes for therapeutic development as a part of the Protein Chemistry team. He has spent the last decade researching gene editing technologies and double-strand DNA repair pathways.

Prior to joining Life Edit, Drew worked as a Scientist at Intellia Therapeutics where he used biochemical and cell-based approaches to analyze gene editing factors to advance the discovery pipeline.

Drew earned his PhD in Biochemistry and Molecular Biology from Clemson University where he characterized enzymes central to homology-directed repair, a critical pathway for repair of DNA double-strand breaks.

Connect with

Visionary science, driven by visionary values.

Our Mission

To rewrite the future by curing disease, making any edit, anywhere.

Our Vision

To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.

Our Values

We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.